Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Revenue

Corcept Therapeutics had revenue of $523.53M in the twelve months ending March 31, 2024, with 26.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $146.81M with 38.95% year-over-year growth. In the year 2023, Corcept Therapeutics had annual revenue of $482.38M with 20.04% growth.

• Revenue (ttm): $523.53M
• Revenue Growth: +26.51%
• P/S Ratio: 4.77
• Revenue / Employee: $1,487,298
• Employees: 352
• Market Cap: 2.50B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	482.38M	80.52M	20.04%
Dec 31, 2022	401.86M	35.88M	9.80%
Dec 31, 2021	365.98M	12.10M	3.42%
Dec 31, 2020	353.87M	47.39M	15.46%
Dec 31, 2019	306.49M	55.24M	21.99%
Dec 31, 2018	251.25M	92.05M	57.82%
Dec 31, 2017	159.20M	77.88M	95.77%
Dec 31, 2016	81.32M	31.04M	61.72%
Dec 31, 2015	50.29M	23.74M	89.39%
Dec 31, 2014	26.55M	16.19M	156.36%
Dec 31, 2013	10.36M	7.05M	213.18%
Dec 31, 2012	3.31M	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	29.00K	-180.00K	-86.12%
Dec 31, 2008	209.00K	-273.00K	-56.64%
Dec 31, 2007	482.00K	188.00K	63.95%
Dec 31, 2006	294.00K	-	-
Dec 31, 2005	0	-	-
Dec 31, 2004	0	-	-
Dec 31, 2003	0	-	-
Dec 31, 2002	0	-	-
Dec 31, 2001	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.